A one health framework to estimate the cost of antimicrobial resistance
Autor: | GM Bruno, Elena Carrara, Marc Mendelson, Souha S. Kanj, Luca Guardabassi, Malgorzata Mikulska, Richard A. Alm, Finola C. Leonard, Evelina Tacconelli, Nico T. Mutters, Sabiha Y. Essack, Jesus Rodriguez Baňo, Kevin Outterson, Tomislav Kostyanev, Herman Goossens, Alessandra Bandera, Peter Søgaard Jørgensen, Giorgio Colombo, Chantal M. Morel, Ramanan Laxminarayan, Stéphan Juergen Harbarth, Bruno Gonzalez-Zorn, Isabel Frost, Christine Årdal, Marlieke E. A. de Kraker, Luigia Scudeller, Gabriel Levy Hara |
---|---|
Přispěvatelé: | GAP-ONE Network, Ministero della Salute |
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Microbiology (medical) Cost Cost-Benefit Analysis 030106 microbiology Psychological intervention Infections Antimicrobial resistance lcsh:Infectious and parasitic diseases 03 medical and health sciences Indirect costs 0302 clinical medicine Cost of Illness Animals Humans Medicine Pharmacology (medical) lcsh:RC109-216 030212 general & internal medicine Activity-based costing Biology computer.programming_language One health business.industry Research One healt Pharmacology. Therapy Public Health Environmental and Occupational Health Drug Resistance Microbial Health Care Costs Cost-effectiveness analysis Infectious Diseases One Health Risk analysis (engineering) Quantitative analysis (finance) Relevant cost Human medicine business computer Delphi |
Zdroj: | Morel, C M, Alm, R A, Årdal, C, Bandera, A, Bruno, G M, Carrara, E, Colombo, G L, de Kraker, M E A, Essack, S, Frost, I, Gonzalez-Zorn, B, Goossens, H, Guardabassi, L, Harbarth, S, Jørgensen, P S, Kanj, S S, Kostyanev, T, Laxminarayan, R, Leonard, F, Hara, G L, Mendelson, M, Mikulska, M, Mutters, N T, Outterson, K, Baňo, J R, Tacconelli, E, Scudeller, L & the GAP-ON€ network 2020, ' A one health framework to estimate the cost of antimicrobial resistance ', Antimicrobial Resistance and Infection Control, vol. 9, no. 1, 187 . https://doi.org/10.1186/s13756-020-00822-6 Antimicrobial resistance & infection control Antimicrobial Resistance and Infection Control, Vol 9, Iss 1, Pp 1-14 (2020) Digital.CSIC. Repositorio Institucional del CSIC instname Antimicrobial Resistance and Infection Control |
ISSN: | 2047-2994 |
DOI: | 10.1186/s13756-020-00822-6 |
Popis: | [Objectives/purpose] The costs attributable to antimicrobial resistance (AMR) remain theoretical and largely unspecified. Current figures fail to capture the full health and economic burden caused by AMR across human, animal, and environmental health; historically many studies have considered only direct costs associated with human infection from a hospital perspective, primarily from high-income countries. The Global Antimicrobial Resistance Platform for ONE-Burden Estimates (GAP-ON€) network has developed a framework to help guide AMR costing exercises in any part of the world as a first step towards more comprehensive analyses for comparing AMR interventions at the local level as well as more harmonized analyses for quantifying the full economic burden attributable to AMR at the global level. [Methods] GAP-ON€ (funded under the JPIAMR 8th call (Virtual Research Institute) is composed of 19 international networks and institutions active in the field of AMR. For this project, the Network operated by means of Delphi rounds, teleconferences and face-to-face meetings. The resulting costing framework takes a bottom-up approach to incorporate all relevant costs imposed by an AMR bacterial microbe in a patient, in an animal, or in the environment up through to the societal level. [Results] The framework itemizes the epidemiological data as well as the direct and indirect cost components needed to build a realistic cost picture for AMR. While the framework lists a large number of relevant pathogens for which this framework could be used to explore the costs, the framework is sufficiently generic to facilitate the costing of other resistant pathogens, including those of other aetiologies. [Conclusion] In order to conduct cost-effectiveness analyses to choose amongst different AMR-related interventions at local level, the costing of AMR should be done according to local epidemiological priorities and local health service norms. Yet the use of a common framework across settings allows for the results of such studies to contribute to cumulative estimates that can serve as the basis of broader policy decisions at the international level such as how to steer R&D funding and how to prioritize AMR amongst other issues. Indeed, it is only by building a realistic cost picture that we can make informed decisions on how best to tackle major health threats. The creation of the GAP-ONE Network was supported under the framework of the Joint Programming Initiative on Antimicrobial Resistance and funded by the Italian Ministry of Health, within the JPIAMR 8th call, Virtual Research Initiative, 2018. |
Databáze: | OpenAIRE |
Externí odkaz: |